Specialty Pharmacy for Sale — Florida

More pharmacies for sale in Florida

• Retail & Compounding Pharmacy

  Florida

  New

  Profitable pharmacy in Western Florida doing both retail and compounding. Annual sales of $1.8 Million and filling 15,000 prescriptions per year with an estimated inventory of $55,000. Net to owner in 2025 after fully staffed was $363,000.

  Annual revenue

  1.8 Million

  Listed by Pharmacy Consulting Broker Services (PCBS)

• Retail & Compounding Pharmacy

  Florida

  New

  Highly profitable pharmacy in Western Florida doing both retail and compounding. Annual sales of $2.9 Million and filling 32,000 prescriptions per year with an estimated inventory of $90,000. Net to owner in 2025 after fully staffed was $1.1 Million.

  Annual revenue

  2.9 Million

  Listed by Pharmacy Consulting Broker Services (PCBS)

• Long-Term Care Pharmacy

  Florida

  New

  PRIME exits and American HealthCare Capital is proud to exclusively represent an independent retail and LTC pharmacy with a proven track record based in the Tampa Bay area of Florida. This retail and long-term care combination pharmacy has operated successfully for over 11 years, building a loyal customer base. Key points of value include:

  Annual revenue

  $3,100,000

  Listed by American HealthCare Capital (PRIME exits)

• Independent Pharmacy

  Florida

  New

  Company Overview American HealthCare Capital is pleased to introduce a retail pharmacy business for sale headquartered in Central Florida. This long-standing pharmacy has been proudly serving the local community for decades. At present, they average 300 prescriptions per day consisting of 50% new prescriptions and 50% refills. Financial Overview The retail pharmacy business for sale in Central Florida has seen growth over the past few years. They grew from gross revenue of $5.5 million in 2020 to $6.6 million in 2021 with an EBITDA of $500,000. Based on results from the first half of the year, 2022 is in line with 2021 with respect to both revenue and EBITDA. Staffing Overview All the staff in this Central Florida pharmacy is expected to stay on under new ownership, including 2 Registered Pharmacists, 3 Certified Pharmacy Techs, and 5 Cashiers. Asking Price The asking price for this pharmacy for sale in Florida is $2.1 million.

  Asking price

  $2,100,000

  Annual revenue

  $6,600,000

  Listed by American HealthCare Capital (PRIME exits)

• Specialty Pharmacy

  Florida

  New

  American HealthCare Capital is proud to introduce a full-service pharmacy located in Florida, offering the following specialty medications: dermatology, fertility, gastroenterology, hepatitis C, rheumatology, oncology, organ transplant, pain management and urology. They were a traditional retail pharmacy until their URAC accreditation in 2020, which expanded their focus and opportunity to drive dramatic future growth. Shipping to all 50 states and leveraging McKesson Specialty Supply Chain, they are capable of 300%-500% annual growth. This opportunity does not include any of the existing accounts. The sellers are in the process of moving their current accounts to their other pharmacy, so this transaction will be for the purchase of the existing retail and specialty pharmacy, its URAC certifications for specialty in all 50 states, their mail order licenses in 50 states, and their contracts with all the large and smaller pharmaceutical distribution and supply companies. The pharmacy employs 2 pharmacists, one of whom is an experienced specialty pharmacist, and 3 Pharmacy Technicians. They are all willing to stay under new ownership. The asking price for this opportunity is $1 million.

  Asking price

  $1,000,000

  Listed by American HealthCare Capital (PRIME exits)

• Specialty Pharmacy with Compounding

  Florida

  New

  American HealthCare Capital is pleased to present a 340b pharmacy providing Specialty, Retail, and Compounding medications to patients throughout the state of Florida. The pharmacy has been in business since 2013 and has been growing steadily over the past four years. Their medication therapies have been focused on Dermatology, Crohn’s/GI, Hepatitis, HIV/Aids, Multiple Sclerosis, Oncology, Rheumatology, Ophthalmology, and Transplant. In recent months there has been tremendous growth into other therapies, such as autoimmune. The specialty pharmacy revenue and patient growth is bolstered by the implementation of proprietary software built on the platform of PioneerRX. Their software allows them to track the entire patient continuum and ensure therapeutic compliance with detailed documentation. The data they generate is proprietary, some of which they sell back to drug manufacturers. The company’s payer mix is 97% Medicare and Medicaid and 3% Cash. Gross revenues have shown consistent growth over the years. In 2017, gross revenues exceeded their projections for the year at $52,800,000, with an adjusted EBITDA of $1,914,000. They are expecting gross revenues to grow 20% in 2018. The current owners have decided to step away from the business to address personal issues, but are willing to stay involved to ensure a smooth transition and future growth of the company. The entire staff, including an experienced Pharmacist-in-Charge are expected to stay on with the new ownership. The asking price for this opportunity is $9.75 Million plus inventory.

  Asking price

  $9,750,000

  Annual revenue

  $53,000,000

  Listed by American HealthCare Capital (PRIME exits)